Non-coding RNAs in muscle differentiation and musculoskeletal disease.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27249675)

Published in J Clin Invest on June 01, 2016

Authors

Monica Ballarino, Mariangela Morlando, Alessandro Fatica, Irene Bozzoni

Articles citing this

Divergent lncRNAs take the lead on pluripotent cell differentiation. Stem Cell Investig (2016) 0.75

Articles cited by this

(truncated to the top 100)

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21

Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 20.59

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet (2005) 17.07

Antisense transcription in the mammalian transcriptome. Science (2005) 15.69

Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23

Genome regulation by long noncoding RNAs. Annu Rev Biochem (2012) 11.70

Non-coding RNA. Hum Mol Genet (2006) 10.57

A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell (2007) 9.33

A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell (2011) 9.24

Natural RNA circles function as efficient microRNA sponges. Nature (2013) 8.93

Circular RNAs are a large class of animal RNAs with regulatory potency. Nature (2013) 8.54

Modular regulatory principles of large non-coding RNAs. Nature (2012) 7.42

Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell (2010) 6.88

Long noncoding RNAs: cellular address codes in development and disease. Cell (2013) 6.01

Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77

Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat Genet (2002) 5.51

A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell (2009) 5.28

A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature (2013) 5.18

MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (2009) 5.17

The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol (2006) 4.31

Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene (2006) 4.06

Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A (2007) 3.72

Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell (2013) 3.35

The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell (2013) 3.27

A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J (2010) 3.18

The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell (2013) 3.14

MicroRNA regulatory networks in cardiovascular development. Dev Cell (2010) 3.09

MicroRNA control of muscle development and disease. Curr Opin Cell Biol (2009) 3.04

MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab (2010) 2.99

X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell (2013) 2.96

Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev (2010) 2.96

Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat Chem Biol (2012) 2.95

Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature (2010) 2.85

The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol (2007) 2.81

MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem (2008) 2.81

S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature (2008) 2.74

MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J Appl Physiol (1985) (2006) 2.63

A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell (2015) 2.63

Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development (2001) 2.62

Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development (1999) 2.57

Yeast telomerase RNA: a flexible scaffold for protein subunits. Proc Natl Acad Sci U S A (2004) 2.52

Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A (2010) 2.47

The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest (2009) 2.36

A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell (2012) 2.29

Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci U S A (2009) 2.28

Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet (2002) 2.27

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med (2006) 2.25

MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Biol Chem (2009) 2.24

The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays (2010) 2.23

Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J (2009) 2.22

eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell (2013) 2.12

Long noncoding RNAs in patients with acute myocardial infarction. Circ Res (2014) 2.02

SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs. Genes Dev (2008) 1.97

A long noncoding RNA protects the heart from pathological hypertrophy. Nature (2014) 1.96

MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell (2010) 1.89

microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest (2012) 1.84

miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med (2011) 1.80

HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A (2008) 1.80

The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev (2006) 1.79

Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells. PLoS One (2009) 1.79

Wnt signaling in myogenesis. Trends Cell Biol (2012) 1.79

Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J Mol Cell Cardiol (2014) 1.71

The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem (2007) 1.70

Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res (2014) 1.60

Muscling through the microRNA world. Exp Biol Med (Maywood) (2008) 1.55

Transcriptional enhancers in development and disease. Genome Biol (2012) 1.52

Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One (2011) 1.52

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep (2011) 1.50

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol (2009) 1.47

miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev (2012) 1.46

The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res (2014) 1.46

Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest (1994) 1.41

Regulatory mechanisms at the mouse Igf2/H19 locus. Mol Cell Biol (2001) 1.41

Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell (2012) 1.40

Muscle physiology. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science (2016) 1.35

Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development (2010) 1.28

Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol (2006) 1.25

Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet (2002) 1.24

Ectopic expression of DLK1 protein in skeletal muscle of padumnal heterozygotes causes the callipyge phenotype. Curr Biol (2004) 1.24

Control of myogenesis by rodent SINE-containing lncRNAs. Genes Dev (2013) 1.21

Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur Heart J (2014) 1.20

microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife (2013) 1.18

Molecular genetics of long QT syndrome. Mol Genet Metab (2010) 1.17

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer (2010) 1.16

The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res (2014) 1.16

Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis. EMBO J (2013) 1.12

Muscular weakness in the mdx mouse. J Neurol Sci (1993) 1.11

Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun (2010) 1.11

Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS One (2013) 1.03

HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev (2014) 1.03

Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS One (2013) 1.03

Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J (2013) 1.03

The Kcnq1ot1 long non-coding RNA affects chromatin conformation and expression of Kcnq1, but does not regulate its imprinting in the developing heart. PLoS Genet (2012) 1.02

LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration. Cell Res (2015) 1.00

Circular RNAs: Identification, biogenesis and function. Biochim Biophys Acta (2015) 0.99

MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol Med (2014) 0.98

Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies. Arthritis Rheumatol (2014) 0.97

Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis. FASEB J (2015) 0.96

Articles by these authors

A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell (2011) 9.24

A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell (2005) 9.22

Primary microRNA transcripts are processed co-transcriptionally. Nat Struct Mol Biol (2008) 3.21

MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab (2010) 2.99

Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell (2011) 2.66

Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J (2008) 2.25

MicroRNA profiling in human medulloblastoma. Int J Cancer (2009) 2.12

miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med (2011) 1.80

Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol (2008) 1.68

The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci U S A (2007) 1.68

A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res (2010) 1.58

Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci U S A (2006) 1.55

Transcription-replication encounters, consequences and genomic instability. Nat Struct Mol Biol (2013) 1.54

Coupled RNA processing and transcription of intergenic primary microRNAs. Mol Cell Biol (2009) 1.54

Purified box C/D snoRNPs are able to reproduce site-specific 2'-O-methylation of target RNA in vitro. Mol Cell Biol (2002) 1.50

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep (2011) 1.50

Functional analysis of yeast snoRNA and snRNA 3'-end formation mediated by uncoupling of cleavage and polyadenylation. Mol Cell Biol (2002) 1.49

Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood (2007) 1.48

A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther (2004) 1.48

Purification, cloning, and characterization of XendoU, a novel endoribonuclease involved in processing of intron-encoded small nucleolar RNAs in Xenopus laevis. J Biol Chem (2003) 1.40

FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J (2012) 1.35

Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ Res (2004) 1.33

Microarray detection of novel nuclear RNA substrates for the exosome. Yeast (2006) 1.33

Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene expression through RNA transcript association and interaction with hnRNPs in Drosophila. PLoS Genet (2009) 1.30

The cotranscriptional assembly of snoRNPs controls the biosynthesis of H/ACA snoRNAs in Saccharomyces cerevisiae. Mol Cell Biol (2005) 1.24

Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc Natl Acad Sci U S A (2002) 1.24

Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice. Hum Gene Ther (2008) 1.17

Functional characterization of XendoU, the endoribonuclease involved in small nucleolar RNA biosynthesis. J Biol Chem (2005) 1.13

Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice. Hum Gene Ther (2006) 1.11

Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping. Mol Ther (2010) 1.09

Coupling between snoRNP assembly and 3' processing controls box C/D snoRNA biosynthesis in yeast. EMBO J (2004) 1.09

Yeast Rrp14p is required for ribosomal subunit synthesis and for correct positioning of the mitotic spindle during mitosis. Nucleic Acids Res (2007) 1.06

Stress induces region specific alterations in microRNAs expression in mice. Behav Brain Res (2009) 1.06

NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression. Blood (2009) 1.05

Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223. Haematologica (2010) 1.04

Cic1p/Nsa3p is required for synthesis and nuclear export of 60S ribosomal subunits. RNA (2003) 1.03

The structure of the endoribonuclease XendoU: From small nucleolar RNA processing to severe acute respiratory syndrome coronavirus replication. Proc Natl Acad Sci U S A (2006) 1.01

Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2. Genes Cancer (2011) 0.99

Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model. Mol Ther (2006) 0.97

Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts. Mol Ther (2012) 0.93

Rrp15p, a novel component of pre-ribosomal particles required for 60S ribosome subunit maturation. RNA (2005) 0.93

The role of long noncoding RNAs in the epigenetic control of gene expression. ChemMedChem (2014) 0.93

Gene-mediated restoration of normal myofiber elasticity in dystrophic muscles. Mol Ther (2008) 0.92

Insights into the structure and function of a guide RNP. Nat Struct Biol (2003) 0.92

The position of yeast snoRNA-coding regions within host introns is essential for their biosynthesis and for efficient splicing of the host pre-mRNA. RNA (2006) 0.89

The tumor marker human placental protein 11 is an endoribonuclease. J Biol Chem (2008) 0.87

Biogenesis and function of non-coding RNAs in muscle differentiation and in Duchenne muscular dystrophy. Biochem Soc Trans (2013) 0.86

TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation. Mol Neurobiol (2013) 0.86

Characterization of the sequences encoding for Xenopus laevis box C/D snoRNP Nop56 protein. Biochim Biophys Acta (2002) 0.86

Large-scale purification and crystallization of the endoribonuclease XendoU: troubleshooting with His-tagged proteins. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.85

HUVEC respond to radiation by inducing the expression of pro-angiogenic microRNAs. Radiat Res (2011) 0.85

TOP promoter elements control the relative ratio of intron-encoded snoRNA versus spliced mRNA biosynthesis. J Mol Biol (2004) 0.84

Mir-23a and mir-125b regulate neural stem/progenitor cell proliferation by targeting Musashi1. RNA Biol (2014) 0.84

A nucleolar localizing Rev binding element inhibits HIV replication. AIDS Res Ther (2006) 0.84

CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia. J Hematol Oncol (2014) 0.84

Role of microRNAs in myeloid differentiation. Biochem Soc Trans (2008) 0.83

IFN-α regulates Blimp-1 expression via miR-23a and miR-125b in both monocytes-derived DC and pDC. PLoS One (2013) 0.83

MicroRNAs as prime players in a combinatorial view of evolution. RNA Biol (2008) 0.81

Identification of small-molecule inhibitors of the XendoU endoribonucleases family. ChemMedChem (2011) 0.80

U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction. Methods Mol Biol (2012) 0.79

A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase. RNA Biol (2005) 0.78

Identity and ranking of colonic mesenchymal stromal cells. J Cell Physiol (2012) 0.78

Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia. J Biol Chem (2013) 0.77

Role of microRNAs in hematological malignancies. Expert Rev Hematol (2009) 0.77

Acute stress alters amygdala microRNA miR-135a and miR-124 expression: inferences for corticosteroid dependent stress response. PLoS One (2013) 0.77

Non coding RNA in muscle differentiation and disease. Microrna (2013) 0.75

Additive and antagonist effects of therapeutic gene combinations for suppression of HIV-1 infection. Antiviral Res (2002) 0.75